Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04833959
Status:
WITHDRAWN
Last Update Posted:
2024-06-21
First Post:
2021-04-02
Brief Title:
Pilot Study of 89-Zr Panitumumab in Pancreas Cancer
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Pilot Study of 89Zr Panitumumab in Pancreas Cancer
Status:
WITHDRAWN
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Business Decision
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main purpose of the study is to assess the safety of 89Zr-panitumumab as a molecular imaging agent in patients with metastatic pancreas cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2021-03447 | OTHER | CTRP | None |
| PANC0037 | OTHER | None | None |